Doxazosin Tablets
Developed to mitigate urinary outflow obstruction to support muscle relaxation and alleviate strain during micturition.
- Category
- Bladder Health
- Active ingredient
- Doxazosin
- Route
- Oral use
- Form
- Tablet
- Strengths
- 1mg · 2mg · 4mg
The exact manufacturer offered is confirmed by the fulfilment partner before supply.
Prescription and consultation requirements for Doxazosin Tablets vary by destination and are determined by the fulfilment partner.
Doxazosin Tablets details
- Conditions
- Benign Prostatic Hyperplasia · Hypertension
- Alternative names
- cardura
- Therapeutic class
- Alpha-1 Adrenergic Antagonist
- Pharmacological class
- Alpha-Blocker
- Contraindications
- history of orthostatic hypotension
- Minor side effects
- dizziness; headache; fatigue
- Moderate side effects
- postural hypotension; peripheral oedema; nasal congestion
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Onset Time
- 1–2 hours
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Nitrates; Sildenafil
- Age restrictions
- Approved for adults.
Serious side effects
priapism, requires immediate medical attention; severe orthostatic syncope, requires immediate medical attention
Patient summary
developed to mitigate urinary outflow obstruction to support muscle relaxation and alleviate strain during micturition.
Mechanism of action
Relaxes arterial and prostatic smooth muscle by blocking post-synaptic alpha-1 receptors, decreasing urethral resistance.
Pregnancy and breastfeeding
TGA Category C: Safety has not been systematically established in pregnant women. Breastfeeding: Caution advised.
What you will receive
Doxazosin Tablets is a generic medicine sold under the name of its active ingredient, Doxazosin, rather than under a brand.
- The fulfilment partner confirms the offered manufacturer and product before supply.
- Check the active ingredient, strength, form and pack shown at checkout before confirming an order.